Navigation Links
Gene Variations May Predict Antidepressant Response
Date:7/18/2008

Finding could help advance individualized medicine for psychiatric patients

FRIDAY, July 18 (HealthDay News) -- Scientists may have found more evidence that a person's genetic make-up may help determine whether or not they respond to the antidepressant Celexa (citalopram).

Specifically, researchers at the Mayo Clinic have found that variations in the serotonin transporter gene could help select which patients should try this drug, one of the family of medications known as selective serotonin reuptake inhibitors (SSRIs).

Some 10 percent of the American population now take antidepressants, making it the most widely prescribed drug class in the country.

But finding the right antidepressant can be a painful, trial-and-error approach, with physicians not knowing which drug is right for which patient until they've actually tried it.

"Patients want to feel better as quickly as possible, so the idea of trying one drug after another until you find one that works can be discouraging. The development of pharmacogenetic testing will help increase the likelihood of selecting an effective drug the first time," study senior author Dr. V. David Mrazek, chairman of the Mayo Clinic's department of psychiatry and psychology, said in a clinic news release. Mrazek is also director of the Clinic's Genomic Expression and Neuropsychiatric Evaluation (GENE) Unit.

Mrazek and his colleagues looked at the serotonin transporter gene, SLC6A4, in about 2,000 individuals.

White patients who had two variations of the gene were more likely to get help from Celexa. There appeared to be no link between the two variations and the odds of remission in black or Hispanic patients.

"The findings of this study represent another step in advancing individualized medicine for psychiatric patients," Mrazek said.

The study was published in the current issue of the American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.

More information

The National Institute of Mental Health has more on depression.



-- HeathDay Staff



SOURCE: Mayo Clinic, news release, July 14, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Study shows gene variations may predict risk of breast cancer in women
2. Genetic variations raise lung cancer risk for smokers and ex-smokers
3. New report highlights variations in approaches to thoracic surgery in the United Kingdom and Ireland
4. Study Finds Variations in Doses of Radiation Therapy
5. More Gene Variations Found That Raise Prostate Cancer Risk
6. Study questions impact of hemoglobin variations on mortality in dialysis patients
7. Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations
8. Climatic variations influence the emergence of cholera in Africa
9. New research from Rhode Island Hospital may help predict outcomes for stomach cancer patients
10. NOAA and Louisiana scientists predict largest Gulf of Mexico dead zone on record
11. Recent Genetic Discoveries Dont Improve Prediction of Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... Engineers at ... bio-compatible, because it produces the same kind of electrical energy that the body uses. ... form of moving electrons. This flow of electrons out of the battery is generated ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted Response to ... Department of Health Care Services, will facilitate the development of a hub and ...
(Date:7/24/2017)... ... July 24, 2017 , ... Every year, thousands of dedicated Higher ... InstructureCon. Each annual event is coupled with a dynamic theme like Camp Canvas; this ... theme, Mission: InstructureCon 0017. , To extend their partnership with Canvas beyond the ...
(Date:7/24/2017)... Beach, California (PRWEB) , ... July 24, 2017 ... ... commercialization of autologous fat (adipose) transfer systems announces the issuance of United States ... ‘324 patent) for its adipose filtration technology. The '398 and '324 patents ...
(Date:7/24/2017)... ... July 24, 2017 , ... Paul Vitenas, MD, FACS is excited to report ... invited to attend Allergan’s recent meeting with their Plastics Advisory Board. As one of ... Allergan is bringing a newly defined structure to the aesthetics market. Dr. Vitenas ...
Breaking Medicine News(10 mins):
(Date:7/17/2017)... 17, 2017  MedX Holdings, Inc., the manufacturer and ... and rehabilitation equipment, today announced the national roll out ... considered the gold standard for the treatment of low ... strengthening equipment. How ... physician or practice who prescribe the MedX Home Back ...
(Date:7/13/2017)... 13, 2017  Centurion Medical Products, a leader in medical product ... fecal impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part ... alleviate patient pain while preventing unneeded emergency department admission due to ...
(Date:7/12/2017)... INDIANAPOLIS , July 12, 2017  Eli Lilly and ... settlement agreement with generic companies to resolve pending patent litigation ... Virginia regarding the Cialis ® ... expire on April 26, 2020. As part of the agreement, ... on September 27, 2018. "The unit dose patent ...
Breaking Medicine Technology: